Neuroprotective effects of GLP-1R agonism GLP-1R agonists improve cerebral blood flow (CBF): By enhancing neurovascular coupling, these drugs ensure that blood flow is properly regulated in response to brain activity, improving overall brain function, particularly in obesity and metabolic disorders
doi: 10.1016/j.blre.2006.06.001 171 ManfrediAABaldiniMCameraMBaldisseraEBrambillaMPerettiGet al
No regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved 5-Amino-1MQ as a drug for human or veterinary use
citizens crossing the border for Ozempic
This loss of dopamine disrupts brain activity, causing motor symptoms like tremors, slowness of movement, and rigidity
Even a little bit helps more than not doing it at all